Aclaris Therapeutics, Inc. ( ACRS) - Stock Earnings
ACRS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
ACRS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -19.8 million USD | 1.3 million USD |
| 2026Q1 | -19.8 million USD | 2.0 million USD |
| 2026Q2 | -21.5 million USD | 1.6 million USD |
| 2027Q2 Est. | — | — |
ACRS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.5 million USD | 31.2 million USD |
| 2024 | -132.1 million USD | 18.7 million USD |
| 2025 | -64.9 million USD | 7.8 million USD |
| 2026 Est. | — | — |
ACRS
Price: $3.75
Earnings Per Share: -0.58 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 2.0 million
Ebitda: -18.6 millionMarket Capitalization: 596.4 million